1. Imaging of Uveal Melanoma—Current Standard and Methods in Development
- Author
-
Małgorzata Solnik, Natalia Paduszyńska, Anna M. Czarnecka, Kamil J. Synoradzki, Yacoub A. Yousef, Tomasz Chorągiewicz, Robert Rejdak, Mario Damiano Toro, Sandrine Zweifel, Katarzyna Dyndor, Michał Fiedorowicz, Solnik, M., Paduszynska, N., Czarnecka, A. M., Synoradzki, K. J., Yousef, Y. A., Choragiewicz, T., Rejdak, R., Toro, M. D., Zweifel, S., Dyndor, K., and Fiedorowicz, M.
- Subjects
Cancer Research ,diagnosi ,PET ,Oncology ,OCT ,SPECT ,imaging ,ultrasonography ,uveal melanoma ,CT ,MRI - Abstract
Uveal melanoma is the most common primary intraocular malignancy in adults, characterized by an insidious onset and poor prognosis strongly associated with tumor size and the presence of distant metastases, most commonly in the liver. Contrary to most tumor identification, a biopsy followed by a pathological exam is used only in certain cases. Therefore, an early and noninvasive diagnosis is essential to enhance patients’ chances for early treatment. We reviewed imaging modalities currently used in the diagnostics of uveal melanoma, including fundus imaging, ultrasonography (US), optical coherence tomography (OCT), single-photon emission computed tomography (SPECT), fundus fluorescein angiography (FFA), indocyanine green angiography (ICGA), fundus autofluorescence (FAF), as well as positron emission tomography/computed tomography (PET/CT) or magnetic resonance imaging (MRI). The principle of imaging techniques is briefly explained, along with their role in the diagnostic process and a summary of their advantages and limitations. Further, the experimental data and the advancements in imaging modalities are explained. We describe UM imaging innovations, show their current usage and development, and explain the possibilities of utilizing such modalities to diagnose uveal melanoma in the future.
- Published
- 2022